

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | alanine transport (GO:0032328) | 5.20232159 |
| 2 | regulation of sequestering of triglyceride (GO:0010889) | 4.79984460 |
| 3 | biotin metabolic process (GO:0006768) | 4.12198012 |
| 4 | low-density lipoprotein particle clearance (GO:0034383) | 4.02081482 |
| 5 | L-serine transport (GO:0015825) | 4.01923032 |
| 6 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.94860509 |
| 7 | regulation of synapse structural plasticity (GO:0051823) | 3.81401005 |
| 8 | serine transport (GO:0032329) | 3.73200500 |
| 9 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.61933502 |
| 10 | sodium ion export (GO:0071436) | 3.56465848 |
| 11 | cell communication by electrical coupling (GO:0010644) | 3.54875626 |
| 12 | carnitine shuttle (GO:0006853) | 3.54397405 |
| 13 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.50292905 |
| 14 | behavioral response to nicotine (GO:0035095) | 3.50141882 |
| 15 | fatty acid transmembrane transport (GO:1902001) | 3.43941667 |
| 16 | cellular response to ATP (GO:0071318) | 3.40874526 |
| 17 | L-amino acid import (GO:0043092) | 3.38824993 |
| 18 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.38543110 |
| 19 | cellular potassium ion homeostasis (GO:0030007) | 3.31801288 |
| 20 | white fat cell differentiation (GO:0050872) | 3.31181776 |
| 21 | detection of light stimulus involved in visual perception (GO:0050908) | 3.26685233 |
| 22 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.26685233 |
| 23 | regulation of cholesterol storage (GO:0010885) | 3.24729368 |
| 24 | amino acid import (GO:0043090) | 3.23371075 |
| 25 | brown fat cell differentiation (GO:0050873) | 3.22922307 |
| 26 | positive regulation of fatty acid oxidation (GO:0046321) | 3.19031537 |
| 27 | response to dietary excess (GO:0002021) | 3.15019598 |
| 28 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.09802279 |
| 29 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 3.09076181 |
| 30 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.08712262 |
| 31 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.07415218 |
| 32 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.06584384 |
| 33 | proline transport (GO:0015824) | 3.05890275 |
| 34 | valine metabolic process (GO:0006573) | 3.05510363 |
| 35 | potassium ion import (GO:0010107) | 3.05115698 |
| 36 | carnitine transmembrane transport (GO:1902603) | 3.03558837 |
| 37 | glial cell proliferation (GO:0014009) | 3.02128906 |
| 38 | regulation of fatty acid oxidation (GO:0046320) | 2.97454968 |
| 39 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.96362687 |
| 40 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.96230199 |
| 41 | cellular response to cholesterol (GO:0071397) | 2.93807512 |
| 42 | regulation of cytokine production involved in inflammatory response (GO:1900015) | 2.93717550 |
| 43 | positive regulation of cholesterol efflux (GO:0010875) | 2.92472886 |
| 44 | neuronal action potential propagation (GO:0019227) | 2.92283643 |
| 45 | cellular sodium ion homeostasis (GO:0006883) | 2.87656107 |
| 46 | postsynaptic membrane organization (GO:0001941) | 2.85945827 |
| 47 | positive regulation of protein kinase C signaling (GO:0090037) | 2.85927508 |
| 48 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.81970034 |
| 49 | phagocytosis, recognition (GO:0006910) | 2.78784507 |
| 50 | fatty acid beta-oxidation (GO:0006635) | 2.78181722 |
| 51 | urinary tract smooth muscle contraction (GO:0014848) | 2.77603758 |
| 52 | apoptotic cell clearance (GO:0043277) | 2.76106414 |
| 53 | fatty acid homeostasis (GO:0055089) | 2.75242904 |
| 54 | gamma-aminobutyric acid transport (GO:0015812) | 2.75144879 |
| 55 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.72506433 |
| 56 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.70494116 |
| 57 | triglyceride catabolic process (GO:0019433) | 2.70390314 |
| 58 | amino-acid betaine transport (GO:0015838) | 2.69977599 |
| 59 | carnitine transport (GO:0015879) | 2.69977599 |
| 60 | regulation of membrane repolarization (GO:0060306) | 2.67826772 |
| 61 | lipid particle organization (GO:0034389) | 2.66857521 |
| 62 | cGMP-mediated signaling (GO:0019934) | 2.66640988 |
| 63 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.65508524 |
| 64 | glycine transport (GO:0015816) | 2.61441513 |
| 65 | adenosine receptor signaling pathway (GO:0001973) | 2.58840558 |
| 66 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.58190174 |
| 67 | triglyceride biosynthetic process (GO:0019432) | 2.58140895 |
| 68 | C4-dicarboxylate transport (GO:0015740) | 2.56937075 |
| 69 | dendritic spine morphogenesis (GO:0060997) | 2.56252581 |
| 70 | alpha-linolenic acid metabolic process (GO:0036109) | 2.55755351 |
| 71 | chondroitin sulfate catabolic process (GO:0030207) | 2.55537943 |
| 72 | axoneme assembly (GO:0035082) | 2.54472918 |
| 73 | central nervous system myelination (GO:0022010) | 2.52308440 |
| 74 | axon ensheathment in central nervous system (GO:0032291) | 2.52308440 |
| 75 | positive regulation of macrophage cytokine production (GO:0060907) | 2.51880264 |
| 76 | membrane depolarization during action potential (GO:0086010) | 2.50985428 |
| 77 | neuromuscular synaptic transmission (GO:0007274) | 2.50480211 |
| 78 | thioester biosynthetic process (GO:0035384) | 2.50150826 |
| 79 | acyl-CoA biosynthetic process (GO:0071616) | 2.50150826 |
| 80 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.49815596 |
| 81 | negative regulation of response to reactive oxygen species (GO:1901032) | 2.48700414 |
| 82 | acylglycerol biosynthetic process (GO:0046463) | 2.48604155 |
| 83 | neutral lipid biosynthetic process (GO:0046460) | 2.48604155 |
| 84 | response to gravity (GO:0009629) | 2.48584201 |
| 85 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.48300964 |
| 86 | regulation of skeletal muscle contraction (GO:0014819) | 2.47858759 |
| 87 | neutral lipid catabolic process (GO:0046461) | 2.47462543 |
| 88 | acylglycerol catabolic process (GO:0046464) | 2.47462543 |
| 89 | positive regulation of sterol transport (GO:0032373) | 2.47452325 |
| 90 | positive regulation of cholesterol transport (GO:0032376) | 2.47452325 |
| 91 | ovulation cycle (GO:0042698) | 2.46967232 |
| 92 | positive regulation of histone deacetylation (GO:0031065) | 2.46468413 |
| 93 | glycogen catabolic process (GO:0005980) | 2.45774627 |
| 94 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.44681174 |
| 95 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.44416239 |
| 96 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.43215362 |
| 97 | modulation by symbiont of host defense response (GO:0052031) | 2.43184052 |
| 98 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.43184052 |
| 99 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.43184052 |
| 100 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.43184052 |
| 101 | modulation by symbiont of host immune response (GO:0052553) | 2.43184052 |
| 102 | positive regulation by symbiont of host defense response (GO:0052509) | 2.43184052 |
| 103 | transepithelial transport (GO:0070633) | 2.42803006 |
| 104 | auditory receptor cell stereocilium organization (GO:0060088) | 2.42519774 |
| 105 | regulation of beta-amyloid formation (GO:1902003) | 2.41871821 |
| 106 | cellular response to sterol (GO:0036315) | 2.41675194 |
| 107 | negative regulation of stress fiber assembly (GO:0051497) | 2.41291013 |
| 108 | positive regulation of lipid storage (GO:0010884) | 2.40945142 |
| 109 | regulation of glycogen (starch) synthase activity (GO:2000465) | 2.40897846 |
| 110 | mannose metabolic process (GO:0006013) | 2.40522818 |
| 111 | L-fucose catabolic process (GO:0042355) | 2.39957803 |
| 112 | fucose catabolic process (GO:0019317) | 2.39957803 |
| 113 | L-fucose metabolic process (GO:0042354) | 2.39957803 |
| 114 | mitotic cell cycle arrest (GO:0071850) | 2.39470205 |
| 115 | response to auditory stimulus (GO:0010996) | 2.39056933 |
| 116 | potassium ion homeostasis (GO:0055075) | 2.38741430 |
| 117 | cell communication involved in cardiac conduction (GO:0086065) | 2.38139122 |
| 118 | regulation of memory T cell differentiation (GO:0043380) | 2.36624001 |
| 119 | negative regulation of lipid storage (GO:0010888) | 2.36485471 |
| 120 | regulation of action potential (GO:0098900) | 2.35486949 |
| 121 | lipid oxidation (GO:0034440) | 2.35149505 |
| 122 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.34658251 |
| 123 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 2.34434355 |
| 124 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.34327189 |
| 125 | semaphorin-plexin signaling pathway (GO:0071526) | 2.34198561 |
| 126 | dermatan sulfate metabolic process (GO:0030205) | 2.34126950 |
| 127 | cardiac muscle contraction (GO:0060048) | 2.34104182 |
| 128 | lipid storage (GO:0019915) | 2.33069787 |
| 129 | synaptic transmission, cholinergic (GO:0007271) | 2.33006586 |
| 130 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.32366623 |
| 131 | branched-chain amino acid catabolic process (GO:0009083) | 2.31981247 |
| 132 | auditory behavior (GO:0031223) | 2.30984716 |
| 133 | positive regulation of p38MAPK cascade (GO:1900745) | 2.30859004 |
| 134 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.30310381 |
| 135 | negative regulation of mast cell activation (GO:0033004) | 2.29625750 |
| 136 | response to lipoprotein particle (GO:0055094) | 2.29483415 |
| 137 | cilium movement (GO:0003341) | 2.29037158 |
| 138 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.28940277 |
| 139 | positive regulation of glycogen metabolic process (GO:0070875) | 2.28734980 |
| 140 | dermatan sulfate biosynthetic process (GO:0030208) | 2.28729278 |
| 141 | axonemal dynein complex assembly (GO:0070286) | 2.27338691 |
| 142 | regulation of synapse maturation (GO:0090128) | 2.26395810 |
| 143 | macroautophagy (GO:0016236) | 2.25798509 |
| 144 | synaptic transmission, glutamatergic (GO:0035249) | 2.24868598 |
| 145 | startle response (GO:0001964) | 2.24678768 |
| 146 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.23011178 |
| 147 | cAMP catabolic process (GO:0006198) | 2.20434681 |
| 148 | neuromuscular process controlling posture (GO:0050884) | 2.19773691 |
| 149 | regulation of protein kinase A signaling (GO:0010738) | 2.19598818 |
| 150 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.19263629 |
| 151 | neuronal action potential (GO:0019228) | 2.18796736 |
| 152 | motile cilium assembly (GO:0044458) | 2.18712844 |
| 153 | negative regulation of multicellular organism growth (GO:0040015) | 2.17514307 |
| 154 | cyclic nucleotide catabolic process (GO:0009214) | 2.17088709 |
| 155 | indolalkylamine catabolic process (GO:0046218) | 2.16666317 |
| 156 | tryptophan catabolic process (GO:0006569) | 2.16666317 |
| 157 | indole-containing compound catabolic process (GO:0042436) | 2.16666317 |
| 158 | negative regulation of Rho protein signal transduction (GO:0035024) | 2.14315589 |
| 159 | synaptic vesicle maturation (GO:0016188) | 2.13617982 |
| 160 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.11245828 |
| 161 | epithelial cilium movement (GO:0003351) | 2.07923115 |
| 162 | negative regulation of reactive oxygen species metabolic process (GO:2000378) | 2.06669282 |
| 163 | purinergic receptor signaling pathway (GO:0035587) | 2.05144158 |
| 164 | glutamate receptor signaling pathway (GO:0007215) | 2.04980765 |
| 165 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.03707332 |
| 166 | sialylation (GO:0097503) | 2.03191457 |
| 167 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.01289779 |
| 168 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.01288023 |
| 169 | indolalkylamine metabolic process (GO:0006586) | 2.01076597 |
| 170 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 1.99484049 |
| 171 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:004316 | 1.97929286 |
| 172 | membrane depolarization (GO:0051899) | 1.95809649 |
| 173 | positive regulation of defense response to virus by host (GO:0002230) | 1.95178075 |
| 174 | neurotransmitter-gated ion channel clustering (GO:0072578) | 1.94170480 |
| 175 | kynurenine metabolic process (GO:0070189) | 1.93243418 |
| 176 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 1.93123219 |
| 177 | vocalization behavior (GO:0071625) | 1.92861779 |
| 178 | adult walking behavior (GO:0007628) | 1.92406045 |
| 179 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 1.91322372 |
| 180 | neuronal ion channel clustering (GO:0045161) | 1.91093067 |
| 181 | transmission of nerve impulse (GO:0019226) | 1.90548721 |
| 182 | cAMP metabolic process (GO:0046058) | 1.90217774 |
| 183 | behavioral response to pain (GO:0048266) | 1.89955485 |
| 184 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 1.87466647 |
| 185 | positive regulation of synapse maturation (GO:0090129) | 1.86545453 |
| 186 | cellular response to exogenous dsRNA (GO:0071360) | 1.86542386 |
| 187 | inner ear receptor stereocilium organization (GO:0060122) | 1.86404527 |
| 188 | NAD biosynthetic process (GO:0009435) | 1.85896193 |
| 189 | protein localization to cilium (GO:0061512) | 1.85157489 |
| 190 | synaptic vesicle exocytosis (GO:0016079) | 1.84123558 |
| 191 | negative regulation of protein localization to cell surface (GO:2000009) | 1.83517704 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.65731551 |
| 2 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.37728528 |
| 3 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.25152357 |
| 4 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.07798719 |
| 5 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.06424502 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.02735451 |
| 7 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.02172833 |
| 8 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.99832733 |
| 9 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.95025387 |
| 10 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.85066914 |
| 11 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.85066914 |
| 12 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.84160691 |
| 13 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.83602965 |
| 14 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.78678033 |
| 15 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.73285562 |
| 16 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.70927632 |
| 17 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.70276068 |
| 18 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.69064909 |
| 19 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.64883489 |
| 20 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.63880276 |
| 21 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.60893501 |
| 22 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.57986771 |
| 23 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.57585737 |
| 24 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.56720425 |
| 25 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.55590777 |
| 26 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.55413641 |
| 27 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.55242089 |
| 28 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.54475284 |
| 29 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.49976559 |
| 30 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.49493626 |
| 31 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.49219364 |
| 32 | * P68_20966046_ChIP-Seq_HELA_Human | 1.48962719 |
| 33 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.48819654 |
| 34 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.47469634 |
| 35 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.45467026 |
| 36 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.45467026 |
| 37 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.44528077 |
| 38 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.43946771 |
| 39 | VDR_22108803_ChIP-Seq_LS180_Human | 1.42678087 |
| 40 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.42117865 |
| 41 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.40600567 |
| 42 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.40548766 |
| 43 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.36105155 |
| 44 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.32171613 |
| 45 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.29420036 |
| 46 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.28133556 |
| 47 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.27017214 |
| 48 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.26700198 |
| 49 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.25689294 |
| 50 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.25214959 |
| 51 | * E2F1_20622854_ChIP-Seq_HELA_Human | 1.23484783 |
| 52 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.23426453 |
| 53 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.23076821 |
| 54 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.21942576 |
| 55 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.21146657 |
| 56 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.19696374 |
| 57 | RXR_22108803_ChIP-Seq_LS180_Human | 1.19568736 |
| 58 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.18733553 |
| 59 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.18051904 |
| 60 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.17574088 |
| 61 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.16475026 |
| 62 | ERA_21632823_ChIP-Seq_H3396_Human | 1.16142322 |
| 63 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.15512302 |
| 64 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.14792021 |
| 65 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.14229616 |
| 66 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.14156429 |
| 67 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.14125817 |
| 68 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.13165731 |
| 69 | * OCT4_20526341_ChIP-Seq_ESCs_Human | 1.12705770 |
| 70 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.12622225 |
| 71 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.12274585 |
| 72 | KDM2B_26808549_Chip-Seq_K562_Human | 1.12095862 |
| 73 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.11346666 |
| 74 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.11038317 |
| 75 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09757392 |
| 76 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.09652150 |
| 77 | * OCT4_19829295_ChIP-Seq_ESCs_Human | 1.09526445 |
| 78 | * PHF8_20622854_ChIP-Seq_HELA_Human | 1.08204744 |
| 79 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.08136304 |
| 80 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.07961275 |
| 81 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.07517924 |
| 82 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.06778521 |
| 83 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.06077790 |
| 84 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.05906794 |
| 85 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.05686558 |
| 86 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.05198029 |
| 87 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.05088760 |
| 88 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.02704665 |
| 89 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.02678526 |
| 90 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.02486750 |
| 91 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02252538 |
| 92 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.00950677 |
| 93 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.00299710 |
| 94 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.99504920 |
| 95 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.99348540 |
| 96 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98698783 |
| 97 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.98675925 |
| 98 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.98609046 |
| 99 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.98488122 |
| 100 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.96544192 |
| 101 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.95447912 |
| 102 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.95406722 |
| 103 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.95342167 |
| 104 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.95210985 |
| 105 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.93711699 |
| 106 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.93325004 |
| 107 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.92982465 |
| 108 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.92852413 |
| 109 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.92628561 |
| 110 | TP53_16413492_ChIP-PET_HCT116_Human | 0.92365334 |
| 111 | SPI1_23127762_ChIP-Seq_K562_Human | 0.92260320 |
| 112 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.91902405 |
| 113 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.91650050 |
| 114 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.91512082 |
| 115 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.90842515 |
| 116 | CJUN_26792858_Chip-Seq_BT549_Human | 0.90356651 |
| 117 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.90175218 |
| 118 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.89799836 |
| 119 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.89700723 |
| 120 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.89373714 |
| 121 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.88141426 |
| 122 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.87961175 |
| 123 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.87941992 |
| 124 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.87502669 |
| 125 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.87337559 |
| 126 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.87185659 |
| 127 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.86456904 |
| 128 | AR_25329375_ChIP-Seq_VCAP_Human | 0.86445248 |
| 129 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.86296089 |
| 130 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.85085338 |
| 131 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.84705954 |
| 132 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.84462165 |
| 133 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.83499936 |
| 134 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.83083981 |
| 135 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.83031089 |
| 136 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.82952462 |
| 137 | SA1_27219007_Chip-Seq_Bcells_Human | 0.82791677 |
| 138 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.82567308 |
| 139 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.82567308 |
| 140 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.82394111 |
| 141 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.82200711 |
| 142 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.82091639 |
| 143 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.81874253 |
| 144 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.81670501 |
| 145 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.81364538 |
| 146 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.81309847 |
| 147 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.80425694 |
| 148 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.80048909 |
| 149 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.79905585 |
| 150 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.79435387 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005670_abnormal_white_adipose | 5.53194441 |
| 2 | MP0005171_absent_coat_pigmentation | 3.91980236 |
| 3 | MP0005666_abnormal_adipose_tissue | 3.52933784 |
| 4 | MP0001986_abnormal_taste_sensitivity | 3.42365365 |
| 5 | MP0000751_myopathy | 3.25293995 |
| 6 | * MP0004130_abnormal_muscle_cell | 3.24816189 |
| 7 | MP0003646_muscle_fatigue | 3.23744438 |
| 8 | MP0003690_abnormal_glial_cell | 3.00902645 |
| 9 | MP0002837_dystrophic_cardiac_calcinosis | 2.98804383 |
| 10 | MP0003136_yellow_coat_color | 2.96684559 |
| 11 | MP0002254_reproductive_system_inflammat | 2.83294084 |
| 12 | MP0005423_abnormal_somatic_nervous | 2.78545164 |
| 13 | MP0005174_abnormal_tail_pigmentation | 2.62978130 |
| 14 | MP0001968_abnormal_touch/_nociception | 2.54552354 |
| 15 | MP0005375_adipose_tissue_phenotype | 2.52829896 |
| 16 | MP0004185_abnormal_adipocyte_glucose | 2.45016976 |
| 17 | MP0004215_abnormal_myocardial_fiber | 2.40028880 |
| 18 | MP0004858_abnormal_nervous_system | 2.31579160 |
| 19 | MP0005058_abnormal_lysosome_morphology | 2.22540890 |
| 20 | MP0008438_abnormal_cutaneous_collagen | 2.22438319 |
| 21 | MP0000569_abnormal_digit_pigmentation | 2.11250669 |
| 22 | MP0002971_abnormal_brown_adipose | 1.97200453 |
| 23 | MP0008875_abnormal_xenobiotic_pharmacok | 1.94235918 |
| 24 | MP0000750_abnormal_muscle_regeneration | 1.90119845 |
| 25 | MP0005551_abnormal_eye_electrophysiolog | 1.85689424 |
| 26 | MP0009745_abnormal_behavioral_response | 1.84171158 |
| 27 | MP0004084_abnormal_cardiac_muscle | 1.82436050 |
| 28 | MP0002064_seizures | 1.77488741 |
| 29 | MP0002909_abnormal_adrenal_gland | 1.75150594 |
| 30 | MP0002736_abnormal_nociception_after | 1.74826938 |
| 31 | MP0004036_abnormal_muscle_relaxation | 1.73157208 |
| 32 | MP0000749_muscle_degeneration | 1.72352528 |
| 33 | MP0002972_abnormal_cardiac_muscle | 1.70851015 |
| 34 | MP0004043_abnormal_pH_regulation | 1.69424677 |
| 35 | MP0003635_abnormal_synaptic_transmissio | 1.67589001 |
| 36 | MP0003279_aneurysm | 1.66569065 |
| 37 | MP0009115_abnormal_fat_cell | 1.64147932 |
| 38 | MP0004087_abnormal_muscle_fiber | 1.60231591 |
| 39 | MP0009780_abnormal_chondrocyte_physiolo | 1.57653447 |
| 40 | MP0002653_abnormal_ependyma_morphology | 1.57231004 |
| 41 | MP0009840_abnormal_foam_cell | 1.56226485 |
| 42 | MP0005620_abnormal_muscle_contractility | 1.56226286 |
| 43 | MP0000003_abnormal_adipose_tissue | 1.55171528 |
| 44 | MP0002735_abnormal_chemical_nociception | 1.53625697 |
| 45 | MP0003329_amyloid_beta_deposits | 1.51969311 |
| 46 | MP0003172_abnormal_lysosome_physiology | 1.50814414 |
| 47 | MP0002063_abnormal_learning/memory/cond | 1.50043013 |
| 48 | MP0002572_abnormal_emotion/affect_behav | 1.47921499 |
| 49 | MP0002272_abnormal_nervous_system | 1.47321112 |
| 50 | MP0006138_congestive_heart_failure | 1.46730963 |
| 51 | MP0003950_abnormal_plasma_membrane | 1.45224197 |
| 52 | MP0000013_abnormal_adipose_tissue | 1.44690595 |
| 53 | MP0001958_emphysema | 1.42797201 |
| 54 | MP0003137_abnormal_impulse_conducting | 1.41363255 |
| 55 | MP0001970_abnormal_pain_threshold | 1.39951176 |
| 56 | MP0000604_amyloidosis | 1.39241652 |
| 57 | MP0001544_abnormal_cardiovascular_syste | 1.38395039 |
| 58 | MP0005385_cardiovascular_system_phenoty | 1.38395039 |
| 59 | MP0008775_abnormal_heart_ventricle | 1.36750302 |
| 60 | MP0005167_abnormal_blood-brain_barrier | 1.36126601 |
| 61 | MP0003075_altered_response_to | 1.36032698 |
| 62 | MP0000343_altered_response_to | 1.32983539 |
| 63 | MP0003705_abnormal_hypodermis_morpholog | 1.32409441 |
| 64 | MP0005330_cardiomyopathy | 1.32291425 |
| 65 | MP0002638_abnormal_pupillary_reflex | 1.31203998 |
| 66 | MP0010329_abnormal_lipoprotein_level | 1.31189080 |
| 67 | MP0003828_pulmonary_edema | 1.30907911 |
| 68 | MP0001984_abnormal_olfaction | 1.29589446 |
| 69 | MP0002090_abnormal_vision | 1.27744227 |
| 70 | MP0005334_abnormal_fat_pad | 1.27690714 |
| 71 | MP0004381_abnormal_hair_follicle | 1.27679254 |
| 72 | MP0001853_heart_inflammation | 1.26997986 |
| 73 | MP0003634_abnormal_glial_cell | 1.26592335 |
| 74 | MP0003879_abnormal_hair_cell | 1.26015659 |
| 75 | MP0002106_abnormal_muscle_physiology | 1.24684906 |
| 76 | MP0000015_abnormal_ear_pigmentation | 1.22134060 |
| 77 | MP0002933_joint_inflammation | 1.19746703 |
| 78 | MP0005275_abnormal_skin_tensile | 1.17553996 |
| 79 | MP0005253_abnormal_eye_physiology | 1.17074562 |
| 80 | MP0010630_abnormal_cardiac_muscle | 1.16138791 |
| 81 | MP0005535_abnormal_body_temperature | 1.14596159 |
| 82 | MP0003191_abnormal_cellular_cholesterol | 1.14532930 |
| 83 | MP0008569_lethality_at_weaning | 1.12912270 |
| 84 | MP0003045_fibrosis | 1.12609517 |
| 85 | MP0000759_abnormal_skeletal_muscle | 1.11148643 |
| 86 | MP0002332_abnormal_exercise_endurance | 1.09708398 |
| 87 | MP0004859_abnormal_synaptic_plasticity | 1.07750687 |
| 88 | MP0001502_abnormal_circadian_rhythm | 1.07040587 |
| 89 | MP0002733_abnormal_thermal_nociception | 1.05177134 |
| 90 | MP0005083_abnormal_biliary_tract | 1.05047100 |
| 91 | MP0003566_abnormal_cell_adhesion | 1.04852332 |
| 92 | MP0003633_abnormal_nervous_system | 1.04542879 |
| 93 | MP0001756_abnormal_urination | 1.03356655 |
| 94 | MP0001501_abnormal_sleep_pattern | 1.01936900 |
| 95 | * MP0002118_abnormal_lipid_homeostasis | 1.01792820 |
| 96 | MP0005369_muscle_phenotype | 1.00408032 |
| 97 | MP0003880_abnormal_central_pattern | 0.98765996 |
| 98 | MP0009384_cardiac_valve_regurgitation | 0.97680000 |
| 99 | MP0002067_abnormal_sensory_capabilities | 0.97652143 |
| 100 | MP0002970_abnormal_white_adipose | 0.97275333 |
| 101 | MP0004133_heterotaxia | 0.96676919 |
| 102 | MP0001486_abnormal_startle_reflex | 0.96510852 |
| 103 | MP0004484_altered_response_of | 0.94930729 |
| 104 | MP0002734_abnormal_mechanical_nocicepti | 0.93817870 |
| 105 | MP0005409_darkened_coat_color | 0.93100411 |
| 106 | MP0003011_delayed_dark_adaptation | 0.91588558 |
| 107 | MP0004270_analgesia | 0.90425899 |
| 108 | MP0004233_abnormal_muscle_weight | 0.90220982 |
| 109 | MP0003183_abnormal_peptide_metabolism | 0.89963616 |
| 110 | MP0000230_abnormal_systemic_arterial | 0.88974969 |
| 111 | MP0004924_abnormal_behavior | 0.88605570 |
| 112 | MP0005386_behavior/neurological_phenoty | 0.88605570 |
| 113 | MP0002269_muscular_atrophy | 0.88592361 |
| 114 | MP0000747_muscle_weakness | 0.88075835 |
| 115 | MP0006276_abnormal_autonomic_nervous | 0.87810293 |
| 116 | MP0003195_calcinosis | 0.87428184 |
| 117 | MP0002557_abnormal_social/conspecific_i | 0.86220231 |
| 118 | MP0003632_abnormal_nervous_system | 0.86173468 |
| 119 | MP0003300_gastrointestinal_ulcer | 0.85414682 |
| 120 | MP0003878_abnormal_ear_physiology | 0.84827043 |
| 121 | MP0005377_hearing/vestibular/ear_phenot | 0.84827043 |
| 122 | MP0010386_abnormal_urinary_bladder | 0.83825620 |
| 123 | MP0004510_myositis | 0.83265593 |
| 124 | MP0009046_muscle_twitch | 0.83251486 |
| 125 | MP0001485_abnormal_pinna_reflex | 0.83212829 |
| 126 | MP0004142_abnormal_muscle_tone | 0.82675603 |
| 127 | MP0002229_neurodegeneration | 0.81536110 |
| 128 | MP0001963_abnormal_hearing_physiology | 0.80164952 |
| 129 | MP0005595_abnormal_vascular_smooth | 0.79788989 |
| 130 | MP0005448_abnormal_energy_balance | 0.79598283 |
| 131 | MP0000026_abnormal_inner_ear | 0.79026751 |
| 132 | MP0004885_abnormal_endolymph | 0.78875073 |
| 133 | MP0001881_abnormal_mammary_gland | 0.77228599 |
| 134 | MP0000778_abnormal_nervous_system | 0.76531749 |
| 135 | MP0002998_abnormal_bone_remodeling | 0.76387379 |
| 136 | MP0009278_abnormal_bone_marrow | 0.75800055 |
| 137 | MP0005646_abnormal_pituitary_gland | 0.75799641 |
| 138 | MP0005165_increased_susceptibility_to | 0.73202847 |
| 139 | MP0004272_abnormal_basement_membrane | 0.73040442 |
| 140 | MP0005365_abnormal_bile_salt | 0.72124117 |
| 141 | MP0002127_abnormal_cardiovascular_syste | 0.72123242 |
| 142 | MP0002876_abnormal_thyroid_physiology | 0.72019053 |
| 143 | MP0004085_abnormal_heartbeat | 0.70361528 |
| 144 | MP0008961_abnormal_basal_metabolism | 0.70212557 |
| 145 | MP0003948_abnormal_gas_homeostasis | 0.69735592 |
| 146 | MP0003631_nervous_system_phenotype | 0.69543859 |
| 147 | MP0005645_abnormal_hypothalamus_physiol | 0.69030853 |
| 148 | MP0004145_abnormal_muscle_electrophysio | 0.67784616 |
| 149 | MP0001661_extended_life_span | 0.65647723 |
| 150 | * MP0002078_abnormal_glucose_homeostasis | 0.64318374 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Aplasia involving bones of the upper limbs (HP:0009823) | 4.40222416 |
| 2 | Aplasia of the phalanges of the hand (HP:0009802) | 4.40222416 |
| 3 | Aplasia involving bones of the extremities (HP:0009825) | 4.40222416 |
| 4 | Exercise-induced myalgia (HP:0003738) | 4.24316475 |
| 5 | Difficulty running (HP:0009046) | 4.18889073 |
| 6 | Congenital stationary night blindness (HP:0007642) | 4.12570034 |
| 7 | Genetic anticipation (HP:0003743) | 3.99346277 |
| 8 | Myoglobinuria (HP:0002913) | 3.96867130 |
| 9 | Attenuation of retinal blood vessels (HP:0007843) | 3.56472571 |
| 10 | Rib fusion (HP:0000902) | 3.50089815 |
| 11 | Increased cerebral lipofuscin (HP:0011813) | 3.49528233 |
| 12 | Hyperglycinuria (HP:0003108) | 3.41633588 |
| 13 | Increased connective tissue (HP:0009025) | 3.33764697 |
| 14 | Megalencephaly (HP:0001355) | 3.27612263 |
| 15 | Progressive cerebellar ataxia (HP:0002073) | 3.21942490 |
| 16 | Atrial fibrillation (HP:0005110) | 3.16897647 |
| 17 | Asymmetric septal hypertrophy (HP:0001670) | 3.15826933 |
| 18 | Neurofibrillary tangles (HP:0002185) | 3.14935252 |
| 19 | Acanthosis nigricans (HP:0000956) | 3.03881136 |
| 20 | Hypertriglyceridemia (HP:0002155) | 3.02728793 |
| 21 | Muscle fiber splitting (HP:0003555) | 3.01944495 |
| 22 | Sudden death (HP:0001699) | 3.01916842 |
| 23 | Decreased central vision (HP:0007663) | 2.96113204 |
| 24 | Annular pancreas (HP:0001734) | 2.92052345 |
| 25 | Abnormal drinking behavior (HP:0030082) | 2.90164164 |
| 26 | Polydipsia (HP:0001959) | 2.90164164 |
| 27 | Hyperventilation (HP:0002883) | 2.89822888 |
| 28 | Primary atrial arrhythmia (HP:0001692) | 2.88372104 |
| 29 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.87035290 |
| 30 | Broad metatarsal (HP:0001783) | 2.85327119 |
| 31 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.83737260 |
| 32 | Absent/shortened dynein arms (HP:0200106) | 2.83737260 |
| 33 | Absent speech (HP:0001344) | 2.82143557 |
| 34 | Decreased circulating renin level (HP:0003351) | 2.80440436 |
| 35 | Exercise-induced muscle cramps (HP:0003710) | 2.80215283 |
| 36 | Ketoacidosis (HP:0001993) | 2.79519715 |
| 37 | Ventricular tachycardia (HP:0004756) | 2.76305531 |
| 38 | Abnormality of midbrain morphology (HP:0002418) | 2.74884992 |
| 39 | Molar tooth sign on MRI (HP:0002419) | 2.74884992 |
| 40 | Hemiplegia (HP:0002301) | 2.74590788 |
| 41 | Abnormality of binocular vision (HP:0011514) | 2.73906539 |
| 42 | Diplopia (HP:0000651) | 2.73906539 |
| 43 | Prolonged QT interval (HP:0001657) | 2.73231855 |
| 44 | Lipoatrophy (HP:0100578) | 2.72151899 |
| 45 | Hyporeflexia of lower limbs (HP:0002600) | 2.72024779 |
| 46 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.71435469 |
| 47 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.71067857 |
| 48 | Testicular atrophy (HP:0000029) | 2.69465974 |
| 49 | Oligomenorrhea (HP:0000876) | 2.67761495 |
| 50 | Supraventricular tachycardia (HP:0004755) | 2.65068617 |
| 51 | Pancreatic cysts (HP:0001737) | 2.64845341 |
| 52 | Supraventricular arrhythmia (HP:0005115) | 2.63652532 |
| 53 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.61343448 |
| 54 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.61343448 |
| 55 | Tetraparesis (HP:0002273) | 2.60846730 |
| 56 | Protruding tongue (HP:0010808) | 2.59016480 |
| 57 | Focal seizures (HP:0007359) | 2.58796183 |
| 58 | Bundle branch block (HP:0011710) | 2.58735028 |
| 59 | Nephronophthisis (HP:0000090) | 2.57394659 |
| 60 | Abnormality of glycine metabolism (HP:0010895) | 2.56893847 |
| 61 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.56893847 |
| 62 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.53610567 |
| 63 | Fetal akinesia sequence (HP:0001989) | 2.51686504 |
| 64 | Hydroxyprolinuria (HP:0003080) | 2.51503454 |
| 65 | Abnormality of proline metabolism (HP:0010907) | 2.51503454 |
| 66 | Heart block (HP:0012722) | 2.48768382 |
| 67 | Abnormality of the calf musculature (HP:0001430) | 2.47182239 |
| 68 | Calf muscle hypertrophy (HP:0008981) | 2.47159154 |
| 69 | Akinesia (HP:0002304) | 2.46108367 |
| 70 | Cystic liver disease (HP:0006706) | 2.44292048 |
| 71 | Atrioventricular block (HP:0001678) | 2.43632915 |
| 72 | Turricephaly (HP:0000262) | 2.42997197 |
| 73 | Right ventricular cardiomyopathy (HP:0011663) | 2.41393443 |
| 74 | Supranuclear gaze palsy (HP:0000605) | 2.40449068 |
| 75 | Ventricular arrhythmia (HP:0004308) | 2.39508780 |
| 76 | Hypoalphalipoproteinemia (HP:0003233) | 2.39037077 |
| 77 | Cerebral inclusion bodies (HP:0100314) | 2.37519076 |
| 78 | Hemiparesis (HP:0001269) | 2.37297076 |
| 79 | Pancreatic fibrosis (HP:0100732) | 2.36408338 |
| 80 | Tubular atrophy (HP:0000092) | 2.36399979 |
| 81 | Chronic hepatic failure (HP:0100626) | 2.36317267 |
| 82 | Abnormal atrioventricular conduction (HP:0005150) | 2.36018591 |
| 83 | Joint stiffness (HP:0001387) | 2.35079084 |
| 84 | Adactyly (HP:0009776) | 2.34995019 |
| 85 | Abnormal ciliary motility (HP:0012262) | 2.34789162 |
| 86 | Aplasia of the musculature (HP:0100854) | 2.33862496 |
| 87 | Mesangial abnormality (HP:0001966) | 2.33276877 |
| 88 | True hermaphroditism (HP:0010459) | 2.29862056 |
| 89 | Axonal loss (HP:0003447) | 2.29528976 |
| 90 | Syncope (HP:0001279) | 2.28100438 |
| 91 | Pulmonary artery stenosis (HP:0004415) | 2.26918925 |
| 92 | Large for gestational age (HP:0001520) | 2.25578315 |
| 93 | Gaze-evoked nystagmus (HP:0000640) | 2.23351423 |
| 94 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.23259766 |
| 95 | Obstructive sleep apnea (HP:0002870) | 2.22879929 |
| 96 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.21860966 |
| 97 | Abnormality of the renal medulla (HP:0100957) | 2.20502318 |
| 98 | Increased variability in muscle fiber diameter (HP:0003557) | 2.19948088 |
| 99 | Amyloidosis (HP:0011034) | 2.19196092 |
| 100 | Febrile seizures (HP:0002373) | 2.17392899 |
| 101 | Rhabdomyolysis (HP:0003201) | 2.17364631 |
| 102 | Abnormality of the hepatic vasculature (HP:0006707) | 2.15086927 |
| 103 | Hypoplastic left heart (HP:0004383) | 2.14030898 |
| 104 | Humeroradial synostosis (HP:0003041) | 2.13762687 |
| 105 | Synostosis involving the elbow (HP:0003938) | 2.13762687 |
| 106 | Congenital sensorineural hearing impairment (HP:0008527) | 2.13275891 |
| 107 | Focal motor seizures (HP:0011153) | 2.12651042 |
| 108 | Myotonia (HP:0002486) | 2.12534431 |
| 109 | Cerebral aneurysm (HP:0004944) | 2.11450266 |
| 110 | Global brain atrophy (HP:0002283) | 2.11413211 |
| 111 | Macular degeneration (HP:0000608) | 2.09726125 |
| 112 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.09411610 |
| 113 | Thin bony cortex (HP:0002753) | 2.08890359 |
| 114 | Polyuria (HP:0000103) | 2.08850176 |
| 115 | Congenital hepatic fibrosis (HP:0002612) | 2.08008635 |
| 116 | Dilated cardiomyopathy (HP:0001644) | 2.06144656 |
| 117 | Broad-based gait (HP:0002136) | 2.05413290 |
| 118 | Facial diplegia (HP:0001349) | 2.04590649 |
| 119 | Chorioretinal atrophy (HP:0000533) | 2.02015130 |
| 120 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.01480620 |
| 121 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.01480620 |
| 122 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.01480620 |
| 123 | Choroideremia (HP:0001139) | 2.00178247 |
| 124 | Hemorrhage of the eye (HP:0011885) | 1.99760019 |
| 125 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.99587384 |
| 126 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.99587384 |
| 127 | Abnormality of glycolipid metabolism (HP:0010969) | 1.99587384 |
| 128 | Abnormal EKG (HP:0003115) | 1.98174426 |
| 129 | Dysostosis multiplex (HP:0000943) | 1.97824609 |
| 130 | Clumsiness (HP:0002312) | 1.97574346 |
| 131 | Muscle stiffness (HP:0003552) | 1.95781472 |
| 132 | Postural instability (HP:0002172) | 1.95676221 |
| 133 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.95612539 |
| 134 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.94692536 |
| 135 | Action tremor (HP:0002345) | 1.93903175 |
| 136 | Epileptic encephalopathy (HP:0200134) | 1.93551303 |
| 137 | Myocardial infarction (HP:0001658) | 1.89685038 |
| 138 | Mucopolysacchariduria (HP:0008155) | 1.89547978 |
| 139 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.89547978 |
| 140 | Ketosis (HP:0001946) | 1.88683341 |
| 141 | Intellectual disability, severe (HP:0010864) | 1.87316778 |
| 142 | Bradycardia (HP:0001662) | 1.86899062 |
| 143 | Subcapsular cataract (HP:0000523) | 1.86068969 |
| 144 | Prenatal maternal abnormality (HP:0002686) | 1.85627328 |
| 145 | Loss of speech (HP:0002371) | 1.85115781 |
| 146 | Type 1 muscle fiber predominance (HP:0003803) | 1.84815749 |
| 147 | Impaired smooth pursuit (HP:0007772) | 1.84758458 |
| 148 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.84644550 |
| 149 | Bone cyst (HP:0012062) | 1.83767878 |
| 150 | Type II lissencephaly (HP:0007260) | 1.83573218 |
| 151 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.82737472 |
| 152 | Subaortic stenosis (HP:0001682) | 1.82088543 |
| 153 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.82088543 |
| 154 | Abolished electroretinogram (ERG) (HP:0000550) | 1.82010590 |
| 155 | Abnormal eating behavior (HP:0100738) | 1.81847379 |
| 156 | Gowers sign (HP:0003391) | 1.80324637 |
| 157 | Frequent falls (HP:0002359) | 1.79488551 |
| 158 | Neonatal respiratory distress (HP:0002643) | 1.79028748 |
| 159 | Maternal diabetes (HP:0009800) | 1.78415975 |
| 160 | Left ventricular hypertrophy (HP:0001712) | 1.76191647 |
| 161 | Medial flaring of the eyebrow (HP:0010747) | 1.76110921 |
| 162 | Abnormal urine output (HP:0012590) | 1.75043926 |
| 163 | Proximal amyotrophy (HP:0007126) | 1.74863035 |
| 164 | Enlarged epiphyses (HP:0010580) | 1.72768191 |
| 165 | Hypoalbuminemia (HP:0003073) | 1.69454834 |
| 166 | Abnormal albumin level (HP:0012116) | 1.69454834 |
| 167 | Hypoplasia of the odontoid process (HP:0003311) | 1.68841852 |
| 168 | Bronchomalacia (HP:0002780) | 1.68727480 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | LMTK2 | 4.76082851 |
| 2 | TRIB3 | 4.47648789 |
| 3 | MAPK15 | 4.28564696 |
| 4 | FRK | 4.19958270 |
| 5 | CAMK1D | 3.64198624 |
| 6 | PHKG1 | 3.62556570 |
| 7 | PHKG2 | 3.62556570 |
| 8 | CAMK1G | 3.17896660 |
| 9 | SIK1 | 3.08650946 |
| 10 | TTN | 2.76245364 |
| 11 | PRKD3 | 2.44780044 |
| 12 | WNK4 | 2.17022702 |
| 13 | BCKDK | 2.08847233 |
| 14 | IRAK3 | 2.04843582 |
| 15 | ADRBK2 | 2.04023097 |
| 16 | ACVR1B | 2.02847290 |
| 17 | MARK1 | 1.95150518 |
| 18 | TLK1 | 1.92192076 |
| 19 | RIPK1 | 1.79408575 |
| 20 | PDK4 | 1.75931663 |
| 21 | PDK3 | 1.75931663 |
| 22 | BMPR1B | 1.74876413 |
| 23 | NTRK2 | 1.66617351 |
| 24 | EPHA4 | 1.60337326 |
| 25 | MUSK | 1.59731295 |
| 26 | TNIK | 1.58749867 |
| 27 | BLK | 1.56044967 |
| 28 | TNK2 | 1.52777773 |
| 29 | MAP2K6 | 1.49365764 |
| 30 | PINK1 | 1.42810663 |
| 31 | INSRR | 1.42145427 |
| 32 | PRKAA2 | 1.36765496 |
| 33 | CDK19 | 1.35456904 |
| 34 | OXSR1 | 1.33713090 |
| 35 | ERN1 | 1.30696300 |
| 36 | GRK1 | 1.28936678 |
| 37 | ADRBK1 | 1.26285249 |
| 38 | PKN2 | 1.23982518 |
| 39 | DMPK | 1.23692072 |
| 40 | OBSCN | 1.20649985 |
| 41 | SGK3 | 1.15145318 |
| 42 | MAPKAPK3 | 1.14281077 |
| 43 | MAPK12 | 1.09891184 |
| 44 | SGK2 | 1.09415651 |
| 45 | TAOK3 | 1.04934769 |
| 46 | EPHB1 | 1.02172253 |
| 47 | STK11 | 1.01495665 |
| 48 | MAP4K2 | 0.97667645 |
| 49 | PDGFRA | 0.95894787 |
| 50 | PDK2 | 0.93656283 |
| 51 | SGK494 | 0.91836954 |
| 52 | SGK223 | 0.91836954 |
| 53 | FGFR3 | 0.90820537 |
| 54 | STK38 | 0.89528395 |
| 55 | DAPK2 | 0.88461246 |
| 56 | PRKCH | 0.87620960 |
| 57 | JAK1 | 0.87574005 |
| 58 | PRKAA1 | 0.81382034 |
| 59 | KIT | 0.80832795 |
| 60 | RPS6KA2 | 0.80630067 |
| 61 | DDR2 | 0.79853824 |
| 62 | CAMK1 | 0.79759004 |
| 63 | TAOK2 | 0.79119986 |
| 64 | PTK6 | 0.77044811 |
| 65 | TIE1 | 0.75892690 |
| 66 | PRKD1 | 0.75873590 |
| 67 | MAP3K7 | 0.74841475 |
| 68 | HIPK2 | 0.74560820 |
| 69 | PAK6 | 0.74156726 |
| 70 | TXK | 0.73398121 |
| 71 | PIK3CA | 0.72519306 |
| 72 | TGFBR1 | 0.72231942 |
| 73 | FGR | 0.70680591 |
| 74 | RIPK4 | 0.68516368 |
| 75 | PRKCG | 0.67555955 |
| 76 | RPS6KA6 | 0.67268602 |
| 77 | BMX | 0.66044974 |
| 78 | MAP3K11 | 0.65977139 |
| 79 | ERBB2 | 0.65828442 |
| 80 | PRKD2 | 0.65010453 |
| 81 | PTK2B | 0.63514006 |
| 82 | MYLK | 0.63164199 |
| 83 | PRPF4B | 0.60981469 |
| 84 | ROCK1 | 0.60301557 |
| 85 | GRK5 | 0.60252031 |
| 86 | CSK | 0.58714267 |
| 87 | SIK2 | 0.58597477 |
| 88 | MAP3K13 | 0.57956784 |
| 89 | SGK1 | 0.57604886 |
| 90 | FGFR2 | 0.57423050 |
| 91 | PDPK1 | 0.57246178 |
| 92 | CDC42BPA | 0.56125341 |
| 93 | JAK3 | 0.56038378 |
| 94 | TYRO3 | 0.55564847 |
| 95 | MAP3K6 | 0.53872600 |
| 96 | CAMKK2 | 0.53440294 |
| 97 | TGFBR2 | 0.52616126 |
| 98 | CAMK4 | 0.52482921 |
| 99 | CAMKK1 | 0.52441541 |
| 100 | EPHB2 | 0.51520031 |
| 101 | PDGFRB | 0.51299336 |
| 102 | WNK1 | 0.50771307 |
| 103 | PRKACG | 0.50197576 |
| 104 | MARK2 | 0.49555933 |
| 105 | JAK2 | 0.48754939 |
| 106 | TRPM7 | 0.48547843 |
| 107 | CAMK2A | 0.48274060 |
| 108 | ZAP70 | 0.47937446 |
| 109 | PRKCE | 0.47376336 |
| 110 | AKT3 | 0.46968334 |
| 111 | CASK | 0.46691426 |
| 112 | PKN1 | 0.46028831 |
| 113 | TBK1 | 0.45986839 |
| 114 | RPS6KL1 | 0.45301063 |
| 115 | RPS6KC1 | 0.45301063 |
| 116 | ICK | 0.45023934 |
| 117 | PAK3 | 0.44569911 |
| 118 | RET | 0.44393187 |
| 119 | CDK5 | 0.44008962 |
| 120 | MAP2K4 | 0.43763490 |
| 121 | PRKACA | 0.43166537 |
| 122 | FES | 0.43150005 |
| 123 | GRK7 | 0.42925429 |
| 124 | MAPK7 | 0.41851742 |
| 125 | SRC | 0.41552634 |
| 126 | IGF1R | 0.40970727 |
| 127 | ILK | 0.40015393 |
| 128 | PRKG1 | 0.39684311 |
| 129 | CAMK2B | 0.38859615 |
| 130 | NTRK1 | 0.37908832 |
| 131 | FER | 0.37840907 |
| 132 | HCK | 0.37680507 |
| 133 | EPHA3 | 0.37442853 |
| 134 | PDK1 | 0.37285897 |
| 135 | FGFR4 | 0.36961276 |
| 136 | NTRK3 | 0.34588182 |
| 137 | RPS6KA3 | 0.32362873 |
| 138 | MAPK13 | 0.30765029 |
| 139 | MTOR | 0.30383647 |
| 140 | CAMK2D | 0.29739468 |
| 141 | MAP2K1 | 0.28605844 |
| 142 | MAP2K3 | 0.28573826 |
| 143 | CDK9 | 0.28278817 |
| 144 | AKT2 | 0.27875696 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 4.76499497 |
| 2 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 3.58870376 |
| 3 | Fatty acid metabolism_Homo sapiens_hsa01212 | 3.20418123 |
| 4 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.97261316 |
| 5 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.71630485 |
| 6 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 2.62364329 |
| 7 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.48189416 |
| 8 | * PPAR signaling pathway_Homo sapiens_hsa03320 | 2.43615239 |
| 9 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.34775537 |
| 10 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.08388219 |
| 11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.99974486 |
| 12 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.89497827 |
| 13 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.88644924 |
| 14 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.72822416 |
| 15 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.70034591 |
| 16 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.63692621 |
| 17 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.47366483 |
| 18 | Histidine metabolism_Homo sapiens_hsa00340 | 1.46406719 |
| 19 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.42635775 |
| 20 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.39808008 |
| 21 | Phototransduction_Homo sapiens_hsa04744 | 1.37622934 |
| 22 | Taste transduction_Homo sapiens_hsa04742 | 1.34352570 |
| 23 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.29736569 |
| 24 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.28587466 |
| 25 | Lysosome_Homo sapiens_hsa04142 | 1.28382299 |
| 26 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.21474086 |
| 27 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.18873431 |
| 28 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.15347589 |
| 29 | Sulfur relay system_Homo sapiens_hsa04122 | 1.13368108 |
| 30 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.13051690 |
| 31 | Carbon metabolism_Homo sapiens_hsa01200 | 1.10002895 |
| 32 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.08439602 |
| 33 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.08355337 |
| 34 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.06436805 |
| 35 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.05943778 |
| 36 | Renin secretion_Homo sapiens_hsa04924 | 1.05822746 |
| 37 | Salivary secretion_Homo sapiens_hsa04970 | 1.04157450 |
| 38 | Cocaine addiction_Homo sapiens_hsa05030 | 1.03720347 |
| 39 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.02916113 |
| 40 | * Insulin resistance_Homo sapiens_hsa04931 | 1.02462832 |
| 41 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.02252783 |
| 42 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.01470863 |
| 43 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.01267752 |
| 44 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.99537782 |
| 45 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.97856228 |
| 46 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.97718858 |
| 47 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.96378932 |
| 48 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.94286770 |
| 49 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.94091504 |
| 50 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.93377805 |
| 51 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.88431734 |
| 52 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.87266262 |
| 53 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.87062460 |
| 54 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.86524105 |
| 55 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.86050872 |
| 56 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.85910811 |
| 57 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.84525633 |
| 58 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.83597482 |
| 59 | Insulin secretion_Homo sapiens_hsa04911 | 0.78730543 |
| 60 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.78032495 |
| 61 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.77136041 |
| 62 | Peroxisome_Homo sapiens_hsa04146 | 0.76094096 |
| 63 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.74984591 |
| 64 | Lysine degradation_Homo sapiens_hsa00310 | 0.74875210 |
| 65 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.71830983 |
| 66 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.71325393 |
| 67 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.71284556 |
| 68 | Axon guidance_Homo sapiens_hsa04360 | 0.69335410 |
| 69 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.69308298 |
| 70 | Circadian entrainment_Homo sapiens_hsa04713 | 0.68616610 |
| 71 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.68361776 |
| 72 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.67504286 |
| 73 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.66963531 |
| 74 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.65873254 |
| 75 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.65689617 |
| 76 | Morphine addiction_Homo sapiens_hsa05032 | 0.65232248 |
| 77 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.64975004 |
| 78 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.64450715 |
| 79 | Circadian rhythm_Homo sapiens_hsa04710 | 0.64387281 |
| 80 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.63849987 |
| 81 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.63737894 |
| 82 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.63104830 |
| 83 | Other glycan degradation_Homo sapiens_hsa00511 | 0.62724371 |
| 84 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.62106403 |
| 85 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.60501256 |
| 86 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.60473483 |
| 87 | GABAergic synapse_Homo sapiens_hsa04727 | 0.60245379 |
| 88 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.59481173 |
| 89 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.59189768 |
| 90 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.59167359 |
| 91 | Long-term depression_Homo sapiens_hsa04730 | 0.58930991 |
| 92 | Olfactory transduction_Homo sapiens_hsa04740 | 0.58660242 |
| 93 | Malaria_Homo sapiens_hsa05144 | 0.54094480 |
| 94 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.53434184 |
| 95 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.53277144 |
| 96 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.52931898 |
| 97 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.51836119 |
| 98 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.51387394 |
| 99 | Focal adhesion_Homo sapiens_hsa04510 | 0.51316080 |
| 100 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.50942142 |
| 101 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.49655378 |
| 102 | Viral myocarditis_Homo sapiens_hsa05416 | 0.49280554 |
| 103 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.49051554 |
| 104 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.48740492 |
| 105 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.48609595 |
| 106 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.48103860 |
| 107 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.47965031 |
| 108 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.47751536 |
| 109 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.46877887 |
| 110 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.46035137 |
| 111 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.45937800 |
| 112 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.44957614 |
| 113 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.44716504 |
| 114 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.44704936 |
| 115 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.43827429 |
| 116 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.42349143 |
| 117 | Melanogenesis_Homo sapiens_hsa04916 | 0.42269158 |
| 118 | Mineral absorption_Homo sapiens_hsa04978 | 0.42240306 |
| 119 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.42011039 |
| 120 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.41578938 |
| 121 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.41411219 |
| 122 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.41338250 |
| 123 | Bile secretion_Homo sapiens_hsa04976 | 0.40759831 |
| 124 | ABC transporters_Homo sapiens_hsa02010 | 0.40091986 |
| 125 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.39491784 |
| 126 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.38654864 |
| 127 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.38355723 |
| 128 | Platelet activation_Homo sapiens_hsa04611 | 0.38073570 |
| 129 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.37303934 |
| 130 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.37297188 |
| 131 | Nicotine addiction_Homo sapiens_hsa05033 | 0.37284246 |
| 132 | Long-term potentiation_Homo sapiens_hsa04720 | 0.36992910 |
| 133 | Tuberculosis_Homo sapiens_hsa05152 | 0.36845555 |
| 134 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.35950220 |
| 135 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.35512504 |
| 136 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.34319452 |
| 137 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.34091947 |
| 138 | Amoebiasis_Homo sapiens_hsa05146 | 0.33019220 |
| 139 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.32604086 |
| 140 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.30999573 |
| 141 | Galactose metabolism_Homo sapiens_hsa00052 | 0.30445276 |
| 142 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.30309971 |

